Smoking and common mental disorders in patients with chronic conditions: An analysis of data collected via a web-based screening system.

OBJECTIVE Smoking is the largest preventable cause of death and disability in the UK and remains pervasive in people with mental disorders and in general hospital patients. We aimed to quantify the prevalence of mental disorders and smoking, examining associations between mental disorders and smoking in patients with chronic physical conditions. METHOD Data were collected via routine screening systems implemented across two London NHS Foundation Trusts. The prevalence of mental disorder, current smoking, nicotine dependence and wanting help with quitting smoking were quantified, and the relationships between mental disorder and smoking were examined, adjusting for age, gender and physical illness, with multiple regression models. RESULTS A total of 7878 patients were screened; 23.2% screened positive for probable major depressive disorder, and 18.5% for probable generalised anxiety disorder. Overall, 31.4% and 29.2% of patients with probable major depressive disorder or generalised anxiety disorder respectively were current smokers. Probable major depression and generalised anxiety disorder were associated with 93% and 44% increased odds of being a current smoker respectively. Patients with depressive disorder also reported higher levels of nicotine dependence, and the presence of common mental disorder was not associated with odds of wanting help with quitting smoking. CONCLUSION Common mental disorder in patients with chronic physical health conditions is a risk factor for markedly increased smoking prevalence and nicotine dependence. A general hospital encounter represents an opportunity to help patients who may benefit from such interventions.

[1]  Marc R Meisner,et al.  Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. , 2006, American journal of public health.

[2]  F. Mazzi,et al.  Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[3]  W. Stalman,et al.  Test-retest reliability of the PRIME-MD: limitations in diagnosing mental disorders in primary care. , 2009, European journal of public health.

[4]  R C Frecker,et al.  Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. , 1989, British journal of addiction.

[5]  T V Perneger,et al.  Validity of the Fagerström test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. , 1999, Addiction.

[6]  R. Drake,et al.  Treating co-morbid chronic medical conditions and anxiety/depression , 2011, Epidemiology and Psychiatric Sciences.

[7]  Michael Flores,et al.  Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. , 2014, JAMA.

[8]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[9]  Robert West,et al.  Can We Trust National Smoking Prevalence Figures? Discrepancies Between Biochemically Assessed and Self-Reported Smoking Rates in Three Countries , 2007, Cancer Epidemiology Biomarkers & Prevention.

[10]  Marc R Meisner,et al.  Depressed smokers and stage of change: implications for treatment interventions. , 2004, Drug and alcohol dependence.

[11]  A. Girling,et al.  Change in mental health after smoking cessation: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.

[12]  N. Finer,et al.  Using Intensive Care Technology in the Delivery Room: A New Concept for the Resuscitation of Extremely Preterm Neonates , 2008, Pediatrics.

[13]  K Kroenke,et al.  Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. , 1994, JAMA.

[14]  G. Swan,et al.  Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting. , 2003, Preventive medicine.

[15]  Shari Bolen,et al.  Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review , 2008, Cancer.

[16]  C. Free,et al.  Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support , 2009, Tobacco Control.

[17]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[18]  R. Hubbard,et al.  Prevalence of smoking among patients treated in NHS hospitals in England in 2010/2011: a national audit , 2014, Thorax.

[19]  C. Camargo,et al.  Changes in smoking associated with an acute health event: Theoretical and practical implications , 2007, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[20]  S Woolhandler,et al.  Smoking and mental illness: A population-based prevalence study. , 2000, JAMA.

[21]  J. Pell,et al.  Validity of self-reported smoking status: Comparison of patients admitted to hospital with acute coronary syndrome and the general population. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[22]  P. Rothwell,et al.  External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.

[23]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[24]  R. Beasley Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease , 2007 .

[25]  R. Spitzer Utility of new procedure for diagnosing mental disorders in primary care , 1994 .

[26]  Mark Haddad Depression in adults with a chronic physical health problem: treatment and management. , 2009, International journal of nursing studies.

[27]  C. Yunis,et al.  Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression , 2013, Annals of Internal Medicine.

[28]  H. Huhtala,et al.  Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study. , 2006, The Journal of rheumatology.

[29]  S. Leatherdale,et al.  Assessment of validity of self-reported smoking status. , 2012, Health reports.

[30]  B. Pinto,et al.  Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Hotopf,et al.  Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. , 2014, General hospital psychiatry.

[32]  Stephan Zipfel,et al.  Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. , 2004, Journal of affective disorders.

[33]  Linda Bauld,et al.  The effectiveness of NHS smoking cessation services: a systematic review. , 2010, Journal of public health.

[34]  S. Zubrick,et al.  Non-specific psychological distress, smoking status and smoking cessation: United States National Health Interview Survey 2005 , 2011, BMC public health.

[35]  Til Wykes,et al.  Developing a new model for patient recruitment in mental health services: a cohort study using Electronic Health Records , 2014, BMJ Open.

[36]  Hyon K. Choi,et al.  Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.

[37]  S. Brunak,et al.  Mining electronic health records: towards better research applications and clinical care , 2012, Nature Reviews Genetics.

[38]  Susan M Sawyer,et al.  Health Risk Behaviors in Adolescents With Chronic Conditions , 2008, Pediatrics.

[39]  J. Vestbo,et al.  Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. , 2002, American journal of epidemiology.

[40]  C. Debattista,et al.  Depression and smoking cessation: Does the evidence support psychiatric practice? , 2007, Neuropsychiatric disease and treatment.

[41]  M. Tremblay,et al.  The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[42]  M. Hotopf,et al.  Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial , 2015, Rheumatology.

[43]  S. Hedden,et al.  Cigarette smoking behaviors among adults with serious mental illness in a nationally representative sample. , 2014, Annals of epidemiology.

[44]  Marc R Meisner,et al.  Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. , 2008, American journal of public health.